2 active trials 2 recruiting 1 disease areas
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05316883 | Biomarkers in Clozapine-responding Schizophrenia | Schizophrenia | Recruiting | 2026-01-20 |
| Not applicable | ||||
| NCT06749444 | Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in… | Treatment-refractory Schizophrenia | Recruiting | 2026-01-20 |
Schizophrenia (2)